Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Sep 15  •  12:35PM ET
423.71
Dollar change
-8.51
Percentage change
-1.97
%
IndexRUT P/E- EPS (ttm)-12.85 Insider Own9.53% Shs Outstand22.22M Perf Week-6.63%
Market Cap9.44B Forward P/E110.14 EPS next Y3.85 Insider Trans-6.32% Shs Float20.17M Perf Month14.09%
Enterprise Value8.77B PEG- EPS next Q-1.93 Inst Own106.68% Short Float20.06% Perf Quarter43.35%
Income-281.90M P/S18.32 EPS this Y57.57% Inst Trans-1.56% Short Ratio10.69 Perf Half Y21.63%
Sales515.55M P/B13.53 EPS next Y141.40% ROA-26.65% Short Interest4.05M Perf YTD37.31%
Book/sh31.32 P/C11.78 EPS next 5Y- ROE-36.30% 52W High457.16 -7.32% Perf Year81.85%
Cash/sh35.98 P/FCF- EPS past 3/5Y-14.40% -32.06% ROIC-34.43% 52W Low200.63 111.19% Perf 3Y539.56%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin96.01% Volatility3.88% 3.98% Perf 5Y315.56%
Dividend TTM- EV/Sales17.00 EPS Y/Y TTM49.62% Oper. Margin-60.09% ATR (14)15.43 Perf 10Y496.35%
Dividend Ex-Date- Quick Ratio4.78 Sales Y/Y TTM3421.98% Profit Margin-54.68% RSI (14)57.99 Recom1.31
Dividend Gr. 3/5Y- - Current Ratio5.11 EPS Q/Q73.19% SMA20-0.13% Beta-1.04 Target Price472.47
Payout- Debt/Eq0.18 Sales Q/Q1353.76% SMA5016.46% Rel Volume0.58 Prev Close432.22
Employees528 LT Debt/Eq0.18 EarningsAug 05 BMO SMA20030.09% Avg Volume378.67K Price423.71
IPOFeb 06, 2007 Option/ShortYes / Yes EPS/Sales Surpr.46.54% 31.33% Trades Volume110,101 Change-1.97%
Date Action Analyst Rating Change Price Target Change
Sep-04-25Resumed H.C. Wainwright Buy $500
Feb-28-25Upgrade B. Riley Securities Neutral → Buy $236 → $422
Feb-27-25Reiterated H.C. Wainwright Buy $400 → $405
Jun-28-24Initiated Cantor Fitzgerald Neutral
Jun-11-24Initiated Wolfe Research Outperform $382
Apr-22-24Initiated BofA Securities Underperform $150
Mar-15-24Upgrade B. Riley Securities Sell → Neutral $155 → $270
Mar-06-24Initiated Citigroup Buy $382
Feb-26-24Downgrade B. Riley Securities Neutral → Sell $155
Dec-20-22Reiterated Oppenheimer Outperform $170 → $250
Sep-13-25 07:00AM
Sep-10-25 07:31AM
Sep-04-25 04:05PM
01:14PM
Sep-03-25 08:00AM
11:49PM Loading…
Aug-28-25 11:49PM
08:00AM
Aug-25-25 09:01AM
Aug-21-25 04:05PM
Aug-20-25 12:45PM
Aug-19-25 04:05PM
Aug-18-25 04:08PM
09:34AM
08:05AM
Aug-15-25 11:05AM
09:00AM Loading…
Aug-12-25 09:00AM
Aug-11-25 08:00AM
Aug-08-25 06:35PM
Aug-07-25 04:05PM
Aug-06-25 07:30AM
Aug-05-25 08:15AM
07:11AM
07:00AM
Jul-30-25 08:30AM
05:00AM
Jul-25-25 10:42PM
08:00AM
Jul-24-25 11:47PM
Jul-22-25 08:00AM
Jul-17-25 11:34AM
07:10AM Loading…
07:10AM
Jul-16-25 04:05PM
08:00AM
Jul-02-25 02:46AM
Jun-24-25 12:45PM
Jun-20-25 12:04PM
06:30AM
Jun-17-25 04:05PM
Jun-02-25 08:00AM
May-26-25 11:15AM
May-15-25 07:21PM
May-13-25 09:45AM
May-10-25 07:15AM
May-08-25 11:41PM
May-07-25 08:47AM
May-02-25 03:02AM
May-01-25 10:57PM
01:01PM
10:40AM
08:20AM
07:17AM
07:17AM
07:00AM
Apr-29-25 08:00AM
Apr-18-25 08:00AM
04:46AM
Apr-17-25 10:28AM
Apr-16-25 07:00AM
Apr-15-25 02:37PM
Apr-03-25 11:50AM
Mar-28-25 06:54PM
11:30AM
Mar-21-25 08:30AM
Mar-19-25 10:34PM
Mar-18-25 05:28AM
Mar-11-25 08:00AM
Mar-07-25 05:35AM
Feb-28-25 10:20AM
Feb-27-25 02:05AM
Feb-26-25 11:43PM
12:28PM
11:27AM
07:21AM
07:00AM
06:30AM
Feb-21-25 08:00AM
Feb-12-25 08:00AM
Jan-17-25 08:28AM
Jan-13-25 11:20AM
06:45AM
Jan-03-25 08:00AM
Dec-06-24 06:46AM
Nov-23-24 07:46AM
Nov-22-24 09:55AM
Nov-21-24 05:12PM
Nov-18-24 02:53AM
Nov-14-24 09:12PM
Nov-10-24 09:30AM
Nov-06-24 08:00AM
Nov-04-24 09:55AM
Nov-02-24 12:00PM
Nov-01-24 04:17PM
04:08PM
03:03AM
Oct-31-24 07:28AM
07:00AM
Oct-30-24 08:00AM
Oct-22-24 06:53AM
Oct-21-24 08:00AM
Oct-18-24 08:00AM
Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
William John SiboldOfficer and DirectorSep 09 '25Proposed Sale453.807,2793,303,210Sep 09 09:24 PM
Sibold William JohnPresident and CEOSep 09 '25Sale445.637,2793,243,741102,474Sep 09 09:07 PM
FRED CRAVESFormer DirectorAug 29 '25Proposed Sale431.692,9001,251,896Aug 29 04:06 PM
Sibold William JohnPresident and CEOAug 21 '25Sale400.187,6163,047,756109,753Aug 21 05:44 PM
WILLIAM SIBOLDDirectorAug 21 '25Proposed Sale391.667,6162,982,883Aug 21 04:24 PM
BAKER BROS. ADVISORS LPDirectorAug 20 '25Buy385.1659,90123,071,3661,947,968Aug 20 06:12 PM
BAKER BROS. ADVISORS LPDirectorAug 18 '25Buy373.2137,16413,869,8311,893,120Aug 20 06:12 PM
BAKER BROS. ADVISORS LPDirectorAug 18 '25Buy364.0468,61824,979,8271,859,091Aug 20 06:09 PM
FRED CRAVESFormer DirectorAug 20 '25Proposed Sale390.221,000390,224Aug 20 04:12 PM
Kelley Shannon TGeneral CounselAug 18 '25Sale367.811,304479,6279,173Aug 18 05:33 PM
Shannon KelleyOfficerAug 18 '25Proposed Sale369.84458169,387Aug 18 05:30 PM
FRED CRAVESFormer DirectorAug 18 '25Proposed Sale382.242,000764,481Aug 18 04:23 PM
BATE KENNETHDirectorAug 15 '25Option Exercise16.4610,000164,60012,627Aug 15 06:04 PM
BATE KENNETHDirectorAug 15 '25Sale365.2010,0003,652,0092,627Aug 15 06:04 PM
FRED CRAVESFormer DirectorAug 15 '25Proposed Sale366.704,1001,503,481Aug 15 05:34 PM
KENNETH M BATEDirectorAug 15 '25Proposed Sale365.2010,0003,652,008Aug 15 04:42 PM
FRIEDMAN PAUL ADirectorAug 13 '25Option Exercise9.45129,1721,220,675316,336Aug 13 06:18 PM
FRIEDMAN PAUL ADirectorAug 13 '25Sale370.24129,17247,825,149187,164Aug 13 06:18 PM
FRIEDMAN PAUL ADirectorAug 12 '25Option Exercise9.4543,605412,067230,769Aug 13 05:45 PM
FRIEDMAN PAUL ADirectorAug 11 '25Option Exercise9.453,20330,268190,367Aug 13 05:45 PM
FRIEDMAN PAUL ADirectorAug 12 '25Sale355.6843,60515,509,469187,164Aug 13 05:45 PM
FRIEDMAN PAUL ADirectorAug 11 '25Sale350.273,2031,121,917187,164Aug 13 05:45 PM
Taub RebeccaDirectorAug 12 '25Option Exercise9.4543,263408,835504,307Aug 13 05:33 PM
Taub RebeccaDirectorAug 11 '25Option Exercise9.453,20030,240464,244Aug 13 05:33 PM
Taub RebeccaDirectorAug 12 '25Sale355.6943,26315,388,279461,044Aug 13 05:33 PM
Taub RebeccaDirectorAug 11 '25Sale350.243,2001,120,753461,044Aug 13 05:33 PM
PAUL FRIEDMANDirectorAug 13 '25Proposed Sale359.00129,17246,372,748Aug 13 04:22 PM
REBECCA TAUBDirectorAug 12 '25Proposed Sale349.5043,26315,120,418Aug 12 04:27 PM
PAUL FRIEDMANDirectorAug 12 '25Proposed Sale349.5043,60515,239,948Aug 12 04:26 PM
PAUL FRIEDMANDirectorAug 11 '25Proposed Sale345.733,2031,107,373Aug 11 04:26 PM
REBECCA TAUBDirectorAug 11 '25Proposed Sale345.733,2001,106,336Aug 11 04:26 PM
Taub RebeccaDirectorJul 18 '25Option Exercise9.451,0009,450462,044Jul 22 05:08 PM
Taub RebeccaDirectorJul 18 '25Sale350.001,000350,005461,044Jul 22 05:08 PM
FRIEDMAN PAUL ADirectorJul 18 '25Option Exercise9.451,40013,230188,564Jul 22 05:06 PM
FRIEDMAN PAUL ADirectorJul 18 '25Sale350.031,400490,044187,164Jul 22 05:06 PM
PAUL FRIEDMANDirectorJul 18 '25Proposed Sale348.731,400488,222Jul 18 05:25 PM
REBECCA TAUBDirectorJul 18 '25Proposed Sale348.731,000348,730Jul 18 05:03 PM
FRIEDMAN PAUL ADirectorJul 16 '25Option Exercise9.4526,176247,363213,340Jul 18 04:13 PM
FRIEDMAN PAUL ADirectorJul 17 '25Option Exercise9.452,70025,515189,864Jul 18 04:13 PM
FRIEDMAN PAUL ADirectorJul 16 '25Sale353.4726,1769,252,543187,164Jul 18 04:13 PM
FRIEDMAN PAUL ADirectorJul 17 '25Sale350.482,700946,301187,164Jul 18 04:13 PM
Taub RebeccaDirectorJul 16 '25Option Exercise9.4526,444249,896487,488Jul 18 04:11 PM
Taub RebeccaDirectorJul 17 '25Option Exercise9.452,65725,109463,701Jul 18 04:11 PM
Taub RebeccaDirectorJul 16 '25Sale353.4726,4449,347,063461,044Jul 18 04:11 PM
Taub RebeccaDirectorJul 17 '25Sale350.412,657931,035461,044Jul 18 04:11 PM
REBECCA TAUBDirectorJul 17 '25Proposed Sale344.972,657916,585Jul 17 04:21 PM
PAUL FRIEDMANDirectorJul 17 '25Proposed Sale344.972,700931,419Jul 17 04:20 PM
PAUL FRIEDMANDirectorJul 16 '25Proposed Sale311.1426,1768,144,401Jul 16 04:20 PM
REBECCA TAUBDirectorJul 16 '25Proposed Sale311.1426,4448,227,786Jul 16 04:19 PM
CRAVES FRED BDirectorMar 12 '25Option Exercise100.777,728778,784357,804Mar 14 04:25 PM
CRAVES FRED BDirectorMar 13 '25Option Exercise65.067,742503,695357,818Mar 14 04:25 PM
CRAVES FRED BDirectorMar 12 '25Sale331.847,7282,564,426350,076Mar 14 04:25 PM
CRAVES FRED BDirectorMar 13 '25Sale325.257,7422,518,053350,076Mar 14 04:25 PM
FRED CRAVESDirectorMar 13 '25Proposed Sale325.257,7422,518,054Mar 13 05:03 PM
Dier MardiSVP and CFOMar 10 '25Sale323.0425883,34410,440Mar 12 04:32 PM
FRED CRAVESDirectorMar 12 '25Proposed Sale331.927,4282,465,514Mar 12 04:11 PM
Waltermire Robert E.Senior VP, Chief Pharma Dev.Mar 05 '25Option Exercise87.4914,1131,234,76617,841Mar 07 05:40 PM
Waltermire Robert E.Senior VP, Chief Pharma Dev.Mar 05 '25Sale341.3214,1134,817,1043,728Mar 07 05:40 PM
Kelley Shannon TGeneral CounselMar 03 '25Sale335.00415139,0257,290Mar 05 04:36 PM
Dier MardiSVP and CFOMar 03 '25Sale324.961,961637,2486,914Mar 05 04:31 PM
Huntsman CaroleChief Commercial OfficerMar 03 '25Sale325.981,834597,8408,604Mar 05 04:24 PM
ROBERT WALTERMIREOfficerMar 05 '25Proposed Sale341.3214,1134,817,104Mar 05 04:07 PM
Waltermire Robert E.Senior VP, Chief Pharma Dev.Feb 28 '25Sale341.071,227418,4883,728Mar 04 09:24 PM
Mardi DierOfficerMar 03 '25Proposed Sale325.891,187386,834Mar 03 08:27 PM
SHANNON KELLEYOfficerMar 03 '25Proposed Sale341.27415141,627Mar 03 04:51 PM
CAROLE A HUNTSMANOfficerMar 03 '25Proposed Sale341.271,834625,889Mar 03 04:12 PM
ROBERT WALTERMIREOfficerFeb 28 '25Proposed Sale341.071,227418,488Feb 28 04:59 PM
Daly James MDirectorFeb 27 '25Option Exercise82.9015,4701,282,47817,382Feb 28 04:31 PM
Daly James MDirectorFeb 27 '25Sale347.4515,4705,375,1261,912Feb 28 04:31 PM
BATE KENNETHDirectorFeb 27 '25Option Exercise66.2620,0001,325,28721,912Feb 28 04:30 PM
BATE KENNETHDirectorFeb 27 '25Sale356.4420,0007,128,7591,912Feb 28 04:30 PM
JAMES M DALYDirectorFeb 27 '25Proposed Sale347.4515,4705,375,126Feb 27 04:54 PM
KENNETH M BATEDirectorFeb 27 '25Proposed Sale356.4420,0007,128,758Feb 27 04:51 PM
Huntsman CaroleChief Commercial OfficerJan 24 '25Sale335.24347116,32810,438Jan 27 05:18 PM
Sibold William JohnPresident and CEOJan 24 '25Sale335.241,584531,02054,303Jan 27 05:12 PM
Taub RebeccaPres., R&D, and CMOJan 24 '25Sale335.24648217,236456,662Jan 27 05:07 PM
Waltermire Robert E.Senior VP, Chief Pharma Dev.Jan 24 '25Sale335.2410334,5304,955Jan 27 05:03 PM
Rebecca TaubOfficerJan 24 '25Proposed Sale340.14648220,411Jan 24 06:00 PM
William John SiboldOfficerJan 24 '25Proposed Sale340.141,584538,782Jan 24 06:00 PM
Carole HuntsmanOfficerJan 24 '25Proposed Sale340.14347118,029Jan 24 06:00 PM
Robert E WaltermireOfficerJan 24 '25Proposed Sale340.1410335,034Jan 24 06:00 PM
Kelley Shannon TGeneral CounselJan 17 '25Sale273.4127775,7357,705Jan 17 07:10 PM
Waltermire Robert E.Senior VP, Chief Pharma Dev.Jan 17 '25Sale273.41442120,8475,058Jan 17 07:08 PM
Taub RebeccaPres., R&D, and CMOJan 17 '25Sale273.411,689461,789457,310Jan 17 07:05 PM
Rebecca TaubOfficerJan 17 '25Proposed Sale272.791,689460,742Jan 17 05:30 PM
Shannon KelleyOfficerJan 17 '25Proposed Sale272.7927775,563Jan 17 05:30 PM
Robert E WaltermireOfficerJan 17 '25Proposed Sale272.79442120,573Jan 17 05:30 PM
CRAVES FRED BDirectorDec 03 '24Sale315.313,6001,135,12211,000Dec 05 04:46 PM
CRAVES FRED BDirectorNov 25 '24Sale350.303,4001,191,02814,600Nov 27 04:16 PM
CRAVES FRED BDirectorNov 25 '24Proposed Sale322.7310,0003,227,300Nov 25 04:10 PM
Huntsman CaroleChief Commercial OfficerNov 21 '24Sale316.92688218,04110,785Nov 22 04:30 PM
Carole HuntsmanOfficerNov 21 '24Proposed Sale316.92688218,040Nov 21 04:30 PM
Levy Richard SDirectorNov 07 '24Option Exercise7.365,00036,80016,012Nov 08 05:07 PM
Levy Richard SDirectorNov 07 '24Sale350.005,0001,750,00011,012Nov 08 05:07 PM
RICHARD S LEVYDirectorNov 07 '24Proposed Sale338.225,0001,691,100Nov 07 04:36 PM
Levy Richard SDirectorNov 01 '24Option Exercise7.365,00036,80016,012Nov 05 07:01 PM
Levy Richard SDirectorNov 01 '24Sale300.945,0001,504,70311,012Nov 05 07:01 PM
RICHARD S LEVYDirectorNov 01 '24Proposed Sale259.345,0001,296,700Nov 01 04:47 PM